Understanding how cells release signaling molecules
Fusion pores in endocrine and synaptic exocytosis
This study is looking at how brain and hormone cells release important chemicals that help them communicate, focusing on tiny openings that form when they send out these signals, which could help us understand conditions related to cell communication better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11097216 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which neurons and endocrine cells release important signaling molecules through a process called exocytosis. It focuses on the role of fusion pores, which are tiny openings that form when vesicles merge with cell membranes, allowing neurotransmitters and hormones to be released. Using advanced biophysical techniques, the research aims to track the behavior of these fusion pores and understand how they are regulated by calcium and other biological signals. This could lead to insights into various conditions related to cell signaling and communication.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions affecting neurotransmitter or hormone signaling, such as autism-fragile X syndrome or Bourneville disease.
Not a fit: Patients with conditions unrelated to cell signaling or exocytosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could improve our understanding of diseases related to neurotransmitter and hormone release, potentially leading to new treatments.
How similar studies have performed: Previous research has shown promising results in understanding exocytosis and fusion pores, indicating that this approach has potential for significant advancements.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Jackson, Meyer B. — University of Wisconsin-Madison
- Study coordinator: Jackson, Meyer B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.